BLOG

Paracrine Effect of Stem Cells: What International Patients Should Know

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When people read about stem cell therapy, they often see phrases such as “anti-inflammatory” or “secretes growth factors.” These phrases describe how mesenchymal stem cells (MSCs) are thought to work, but they can be confusing if you are comparing options as an international patient. This article explains what the “paracrine” idea means in plain language, what it does not mean, and which questions are worth bringing to a doctor at Grand Green Osaka Umekita Clinic or any other clinic you are considering.

The short answer: cells may act as signalers, not only as building blocks

Early explanations of stem cells focused on their ability to turn into other cell types, such as fat, bone, or cartilage cells. More recent research has paid attention to a second idea: MSCs release small molecules, including cytokines, growth factors, and tiny vesicles, that may influence nearby cells. This signaling is called the paracrine effect. In this view, the cells may help create an environment that supports tissue repair and calms excessive inflammation, rather than simply replacing damaged cells one by one.

It is important to keep this in proportion. Much of the evidence for paracrine activity comes from laboratory and animal studies, and results in people vary by condition, cell source, dose, and study design. A mechanism seen in a dish does not guarantee a particular result for an individual patient.

What mesenchymal stem cells from fat are reported to do

Mesenchymal stem cells are somatic stem cells found in tissues such as fat and bone marrow. Adipose tissue is considered to contain a relatively large number of them, and it can be collected through a small incision under local anesthesia. In adipose-derived stem cell therapy, a small amount of your own fat tissue is collected, the MSCs are cultured and expanded at a specialized facility, and the cells are then returned by intravenous infusion.

Published reports describe several behaviors of MSCs that are of interest to researchers:

  • Release of anti-inflammatory signals that may modulate immune cell activity
  • Release of growth factors that may support the repair environment of damaged tissue
  • A reported tendency to travel through the bloodstream toward areas of inflammation or injury, often called the homing effect

These are descriptions of reported biological activity. They are not promises of symptom relief, and the strength of evidence differs from one condition to another. Large, well-controlled human trials are still needed for many uses.

Why this matters when you read clinic information

Understanding the paracrine concept helps you read marketing and medical information more critically. If a page says cells “regenerate” tissue or “cure” a condition, that is a stronger claim than the research generally supports. A more careful description would say that the cells are being studied for their possible supportive and anti-inflammatory effects, and that outcomes differ between people.

Responsible information should also make clear that stem cell therapy is not a substitute for standard medical care. If you have osteoarthritis, a chronic inflammatory condition, or any other diagnosis, your existing treatment plan and your regular doctors remain important. A regenerative treatment, if appropriate for you at all, would be something to discuss alongside those options and not instead of them.

The legal and practical context in Japan

In Japan, treatments that use cultured cells are provided under the Act on the Safety of Regenerative Medicine. Clinics must submit a regenerative medicine provision plan that is reviewed by a certified committee, and cell culture is carried out at a facility that meets regulatory requirements. This framework is about safety management and transparency. It does not mean the treatment is guaranteed to work.

Adipose-derived stem cell therapy is offered as a self-pay (non-insured) treatment, so costs are not covered by Japan’s national health insurance. Fees, the number of visits, the culture period, and the risks and possible side effects should all be confirmed directly with the doctor and in the clinic’s written explanation before you decide. Because the process includes fat collection, a culture period, and infusion, it is worth understanding the timeline early if you are traveling to Osaka.

Questions to bring to your consultation

A consultation is the place to turn general information into advice that fits your own health. You may find it useful to ask the following:

  • What is the evidence for my specific condition, and how strong is it?
  • How would this treatment fit with my current medications and standard care?
  • What are the possible risks and side effects, and what follow-up is arranged afterward?
  • What are the total costs, the number of visits, and the expected timeline, including the culture period?
  • Am I a suitable candidate based on my medical history and current health?
  • Can I receive explanations and consent documents in a language I fully understand?

Grand Green Osaka Umekita Clinic, located in the Umeda area of Osaka, has an information page for international patients and offers consultation for people who want to understand regenerative medicine options. Whether the therapy is suitable for you can only be decided by a doctor after an examination.

Summary

The paracrine effect is a useful way to understand why researchers are interested in mesenchymal stem cells: the cells may release signals that influence inflammation and tissue repair. At the same time, much of this evidence is early, and individual results vary. Adipose-derived stem cell therapy in Japan is a self-pay treatment provided under the Act on the Safety of Regenerative Medicine, and it should be considered together with standard care. Before deciding, speak with a doctor about the evidence, risks, side effects, costs, and whether the treatment is appropriate for you.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact